These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9166495)

  • 21. HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancer.
    van Bommel PF; van den Brule AJ; Helmerhorst TJ; Gallee MP; Gaarenstroom KN; Walboomers JM; Meijer CJ; Kenemans P
    Gynecol Oncol; 1993 Mar; 48(3):333-7. PubMed ID: 8385059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-risk human papillomavirus DNA in paraaortic lymph nodes in advanced stages of cervical carcinoma.
    Slama J; Drazdakova M; Dundr P; Fischerova D; Zikan M; Pinkavova I; Freitag P; Fanta M; Kuzel D; Zima T; Cibula D
    J Clin Virol; 2011 Jan; 50(1):46-9. PubMed ID: 21035386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approach to human high-risk papillomavirus (HR-HPV) genotyping.
    Weismanová E; Weismann P; Vizváryová M; Lehotská V; Krizanová O; Repiská V; Kausitz J
    Neoplasma; 2002; 49(4):217-24. PubMed ID: 12382018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of human papillomavirus types 16 and 18 in primary and in metastatic lesions of cervical carcinomas.
    Mvula M; Iwasaka T; Matsuo N; Nakao Y; Kaku T; Hachisuga T; Fukuda K; Tsukamoto N; Sugimori H
    Gynecol Oncol; 1994 May; 53(2):156-60. PubMed ID: 8188074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of high-risk HPV DNA and CK19 in pelvic lymph nodes in stage Ia-IIa cervical cancer and their clinical value.
    Zhang F; Liu D; Lin B; Hao Y; Zhou D; Qi Y; Zhang S
    Oncol Rep; 2012 Jun; 27(6):1801-6. PubMed ID: 22407186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus type 16 oropharyngeal cancers in lymph nodes as a marker of metastases.
    Mirghani H; Moreau F; Lefèvre M; Tam C; Périé S; Soussan P; St Guily JL
    Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):910-4. PubMed ID: 21930979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
    Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
    J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Human papilloma virus and lymphatic metastasis in squamous cell carcinoma of the cervix].
    Bakhidze EV; Lavrinovich OE; Chepik OF; Kiselev OI
    Vopr Onkol; 2011; 57(3):318-21. PubMed ID: 21882602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion.
    Im SS; Wilczynski SP; Burger RA; Monk BJ
    Clin Cancer Res; 2003 Sep; 9(11):4145-50. PubMed ID: 14519638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of oncogenic HPV DNAs in cervical carcinoma tissues and pelvic lymph nodes associating with proliferating cell nuclear antigen expression.
    Park JS; Rhyu KS; Kim CJ; Kim HS; Han KT; Ahn HK; Kim SJ; Namkoong SE
    Gynecol Oncol; 1996 Mar; 60(3):418-23. PubMed ID: 8774650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of HPV DNA in lymph nodes in surgically treated cervical carcinoma patients--a prospective study.
    Lukaszuk K; Liss J; Gulczynski J; Nowaczyk M; Nakonieczny M; Piatkowski M; Sliwinski W; Baay M; Wozniak I; Maj B; Lukaszuk M
    Gynecol Oncol; 2007 Mar; 104(3):721-6. PubMed ID: 17156830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients.
    Lentz SE; Muderspach LI; Felix JC; Ye W; Groshen S; Amezcua CA
    Obstet Gynecol; 2004 Jun; 103(6):1204-10. PubMed ID: 15172853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
    Zheng Y; Peng ZL; Lou JY; Wang H
    Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of human papillomavirus from archival tissues in cervical cancer patients in Mauritius.
    Rughooputh S; Eddoo R; Manraj S; Jeebun N; Greenwell P
    J Clin Virol; 2006 Feb; 35(2):173-8. PubMed ID: 16115796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.
    Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
    Zentralbl Gynakol; 2001 Feb; 123(2):91-101. PubMed ID: 11265139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
    Baser E; Can F; Unlukaplan M; Ayhan A
    Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor.
    Wei LH; Kuo ML; Chen CA; Cheng WF; Cheng SP; Hsieh FJ; Hsieh CY
    Gynecol Oncol; 2001 Jul; 82(1):49-56. PubMed ID: 11426961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study.
    van Muyden RC; ter Harmsel BW; Smedts FM; Hermans J; Kuijpers JC; Raikhlin NT; Petrov S; Lebedev A; Ramaekers FC; Trimbos JB; Kleter B; Quint WG
    Cancer; 1999 May; 85(9):2011-6. PubMed ID: 10223243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.